Rebecca har more than 30 years of experience in influenza research. The key competence of the Influenza Centre is development and clinical evaluation of novel and pandemic vaccines as well as cohort studies of infected patients focusing on immunological responses with long term follow up.

Rebecca won the Meltzer prize for excellent scientific dissemination in 2022 in recognition of her work in public dissemination. She frequently contributes to news through interviews and chronicles on television, the radio, in the newspapers, online and magazines about COVID-19, influenza and vaccines including >400 media interviews during the COVID pandemic. 

Rebecca actively participates in teaching of Virology, Immunology and Vaccinology of undergraduate and postgraduate (masters and Ph.D., medical doctors undergoing specialisation) students in medicine, pharmacy, dentistry and cell biology. She chairs the education committee for the learned society Influenza and other respiratory viruses.

Lecture

• Cox Brokstad, Rebecca Jane (2024). Strategi for Influensavaksinasjon. (external link)
• Cox Brokstad, Rebecca Jane (2024). Long Covid plager hos barn etter deltainfeksjon og omicron-reinfeksjon. (external link)
• Cox, Rebecca Jane (2023). Correlates of Protection. (external link)
• Cox, Rebecca Jane (2023). Human Challenge Models panel discussion. (external link)
• Cox, Rebecca Jane (2022). Influensavaksiner og covid vaksiner . (external link)
• Cox, Rebecca Jane (2022). Post-covid: Balancing concerns for public health and individual autonomy over own health. The specialist/immunology perspective. (external link)
• Cox, Rebecca Jane (2022). Influenza. (external link)
• Cox, Rebecca Jane (2021). Overview of novel platforms in influenza vaccine and integrating lessons from COVID-19. (external link)
• Cox, Rebecca Jane (2021). Covid-19 infection and vaccination in Western Norway . (external link)
• Cox, Rebecca Jane (2021). Vaksinasjon og COVID-19 vaksiner. (external link)
• Cox, Rebecca Jane (2020). Immunitet til COVID-19 i Bergen. (external link)
• Cox, Rebecca Jane (2020). Sanntidsforskning: Når egen forskning blir livsviktig og dagsaktuell/vitenskapsrådgivning. (external link)
• Cox, Rebecca Jane (2018). Vaksinering av helsepersonell hva vet vi?. (external link)

Academic literature review

• Cox, Rebecca Jane; Pathirana, Rishi Delan (2024). Unravelling influenza correlates of protection: lessons from human A/H1N1 Challenge. (external link)
• Meskell, Pauline; Biesty, Linda M; Dowling, Maura et al. (2023). Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis. (external link)
• McKimm-Breschkin, Jennifer L.; Hay, Alan J.; Cao, Bin et al. (2022). COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference. (external link)
• Moore, Kristine A.; Ostrowsky, Julia T.; Kraigsley, Alison M. et al. (2021). A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. (external link)
• Madsen, Anders; Brokstad, Rebecca Jane Cox (2020). Prospects and challenges in the development of universal influenza vaccines. (external link)
• Zhou, Fan; Trieu, Mai Chi; Davies, Richard Allan et al. (2018). Improving influenza vaccines: challenges to effective implementation. (external link)
• Slettevoll, Steffen Aleksander; Parasomthy, Abira; Cox, Rebecca Jane (2018). Influensa-alltid relevant . (external link)
• Mohn, Kristin Greve Isdahl; Smith, Ingrid; Sjursen, Haakon et al. (2017). Immune responses after live attenuated influenza vaccination . (external link)
• Krammer, Florian; Cox, Rebecca Jane (2013). The emergence of H7N9 viruses: A chance to redefine correlates of protection for influenza virus vaccines. (external link)
• Haaheim, Lars Reinhardt; Madhun, Abdullah Sami; Cox, Rebecca Jane (2009). Pandemic influenza vaccines - the challenges. (external link)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Haaheim, Lars Reinhardt (2007). Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients. (external link)
• Cox, Rebecca Jane; Brokstad, Karl; Ogra, Pearay (2004). Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. (external link)

Academic article

• Torgauten, Hilde Marie; Onyango, Therese Bredholt; Ljostveit, Sonja et al. (2024). Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients. (external link)
• Zhou, Fan; Vahokoski, Juha; Langeland, Nina et al. (2024). Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection. (external link)
• Iversen, Arild; Blomberg, Bjørn; Haug, Kjell et al. (2024). Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway. (external link)
• Salmanton-García, Jon; Wipfler, Pauline; Valle-Simón, Paula et al. (2023). VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe. (external link)
• Waldock, Joanna; Remarque, Edmond J.; Zheng, Lingyi et al. (2023). Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study. (external link)
• Argyropoulos, Christos D.; Leckler, Janina; Salmanton-García, Jon et al. (2023). Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit. (external link)
• Beukema, Martin; Gong, Shuran; Al-Jaawni, Kasem et al. (2023). Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice. (external link)
• Hansen, Lena; McMahon, Meagan; Turner, Hannah L. et al. (2023). Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo. (external link)
• Hansen, Lena; Brokstad, Karl Albert; Bansal, Amit et al. (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. (external link)
• Ertesvåg, Nina Urke; Iversen, Arild; Blomberg, Bjørn et al. (2023). Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents. (external link)
• Waldock, Joanna; Weiss, Carol D.; Wang, Wei et al. (2023). An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study. (external link)
• Onyango, Therese Bredholt; Zhou, Fan; Bredholt, Geir et al. (2023). SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients. (external link)
• Waerlop, Gwenn; Leroux-Roels, Geert; Pagnon, Anke et al. (2023). Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols. (external link)
• Kenny, Grace; O’Reilly, Sophie; Wrigley Kelly, Neil et al. (2023). Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time. (external link)
• Wolff, Anette Susanne Bøe; Hansen, Lena; Grytaas, Marianne Aardal et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (external link)
• Poulimeneas, Dimitrios; Koniordou, Markela; Kousi, Dimitra et al. (2023). The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium. (external link)
• Bansal, Amit; Trieu, Mai Chi; Mohn, Kristin Greve-Isdahl et al. (2023). Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. (external link)
• Tran, Trung; Vaage, Eline Benno; Mehta, Adi et al. (2022). Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants. (external link)
• Kittang, Bård Reiakvam; Blomberg, Bjørn; Sævik, Marianne et al. (2022). SARS CoV-2 Infection among Health Care Workers from Different Health Care Facilities in Western Norway: A Prospective, Cross-Sectional Study. (external link)
• Salmanton-García, Jon; Stewart, Fiona A.; Heringer, Sarah et al. (2022). VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment. (external link)
• Sicca, Federica; Sakorafa, Eleni; de Jonge, Anouk et al. (2022). The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority. (external link)
• Ertesvåg, Nina Urke; Cox, Rebecca Jane; Jalloh, Sarah Larteley Lartey et al. (2022). Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses. (external link)
• Ertesvåg, Nina Urke; Xiao, Julie; Zhou, Fan et al. (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. (external link)
• Luís, Catarina; Di Marzo, Verónica Romina; Kaur, Mandeep et al. (2022). Vaccination rates in Europe are not associated with online media intensity. (external link)
• Waerlop, Gwenn; Leroux-Roels, Geert; Lambe, Teresa et al. (2022). Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. (external link)
• Begue, Sarah; Waerlop, Gwenn; Salaun, Bruno et al. (2022). Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4⁺ T cell immunity within the FLUCOP consortium. (external link)
• Bernard, Marie-Clotilde; Waldock, Joanna; Commandeur, Sylvie et al. (2022). Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study. (external link)
• Syre, Heidi; Obreque, Marius Eduardo Brå; Dalen, Ingvild et al. (2022). The performances of three commercially available assays for the detection of SARS‐CoV‐2 antibodies at different time points following SARS‐CoV‐2 infection. (external link)
• Zimmermann, Julie; Schmidt, Signe Tandrup; Trebbien, Ramona et al. (2022). A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease. (external link)
• Mohn, Kristin Greve-Isdahl; Bredholt, Geir; Zhou, Fan et al. (2022). Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. (external link)
• Ekanger, Camilla Tvedt; Zhou, Fan; Bohan, Dana et al. (2022). Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus. (external link)
• Fjelltveit, Elisabeth Berg; Blomberg, Bjørn; Kuwelker, Kanika et al. (2022). Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study. (external link)
• Meskell, Pauline; Biesty, Linda M; Dowling, Maura et al. (2022). Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis. (external link)
• Madsen, Anders; Jul-Larsen, Åsne; Trieu, Mai Chi et al. (2021). Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response. (external link)
• Paramsothy, Abira; Jalloh, Sarah Larteley Lartey; Davies, Richard Allan et al. (2021). Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. (external link)
• Blomberg, Bjørn; Mohn, Kristin Greve-Isdahl; Brokstad, Karl Albert et al. (2021). Long COVID in a prospective cohort of home-isolated patients. (external link)
• Kuwelker, Kanika; Zhou, Fan; Blomberg, Bjørn et al. (2021). Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. (external link)
• Fjelltveit, Elisabeth Berg; Cox, Rebecca Jane; Kittang, Bård Reiakvam et al. (2021). Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study. (external link)
• Bansal, Amit; Trieu, Mai Chi; Mohn, Kristin Greve-Isdahl et al. (2021). Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. (external link)
• Waldock, Joanna; Zheng, Lingyi; Remarque, Edmond J. et al. (2021). Assay harmonization and use of biological standards to improve the reproducibility of the hemagglutination inhibition assay: A FLUCOP collaborative study. (external link)
• Hansen, Lena; Zhou, Fan; Amdam, Håkon et al. (2021). Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers. (external link)
• Diaz Perez, Esperanza; Mamelund, Svenn-Erik; Eid, Jarle et al. (2021). Learning from the COVID-19 pandemic among migrants: An innovative, system-level, interdisciplinary approach is needed to improve public health . (external link)
• Amdam, Håkon; Madsen, Anders; Zhou, Fan et al. (2021). Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014). (external link)
• Zhou, Fan; Hansen, Lena; Pedersen, Gabriel Kristian et al. (2021). Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection. (external link)
• Trieu, Mai Chi; Bansal, Amit; Madsen, Anders et al. (2020). SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (external link)
• Riese, Peggy; Trittel, Stephanie; Pathirana, Rishi et al. (2020). Responsiveness to influenza vaccination correlates with nkg2c-expression on nk cells. (external link)
• Fjelltveit, Elisabeth Berg; Brokstad, Rebecca Jane Cox; Østensjø, Jørgen et al. (2020). Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults. (external link)
• Pollard, Andrew J.; Sauerwein, Robert; Baay, Marc et al. (2020). Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report. (external link)
• Mohn, Kristin Greve Isdahl; Brokstad, Karl Albert; Islam, Shahinul et al. (2020). Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children. (external link)
• Jalloh, Sarah Larteley Lartey; Zhou, Fan; Brokstad, Karl Albert et al. (2020). Live-attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction. (external link)
• Madsen, Anders; Dai, Ya-Nan; McMahon, Meagan et al. (2020). Human antibodies targeting influenza B virus neuraminidase active site are broadly protective. (external link)
• Björk, Albin; Thorlacius, Gudny Ella; Mofors, Johannes et al. (2020). Viral antigens elicit augmented immune responses in primary Sjögren's syndrome. (external link)
• Bodin, Johanna Eva; Mihret, Adane; Holm-Hansen, Carol J C et al. (2019). Vitamin D Deficiency is Associated with Increased Use of Antimicrobials among Preschool Girls in Ethiopia. (external link)
• Ianevski, Aleksandr; Zusinaite, Eva; Shtaida, Nastassia et al. (2019). Low temperature and low UV indexes correlated with peaks of influenza virus activity in Northern Europe during 2010-2018. (external link)
• Madsen, Anders; Azimi, Linda; Tete, Sarah et al. (2019). No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination. (external link)
• Krammer, Florian; Weir, Jerry P.; Engelhardt, Othmar et al. (2019). Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines. (external link)
• Islam, Shahinul; Zhou, Fan; Jalloh, Sarah Larteley Lartey et al. (2019). Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination. (external link)
• Bösl, Korbinian; Ianevski, Aleksandr; Than, Thoa T. et al. (2019). Common nodes of virus-host interaction revealed through an integrated network analysis. (external link)
• Ianevski, Aleksandr; Zusinaite, Eva; Kuivanen, Suvi et al. (2018). Novel activities of safe-in-human broad-spectrum antiviral agents. (external link)
• Olberg, Henning Kristian; Eide, Geir Egil; Cox, Rebecca Jane et al. (2018). Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. (external link)
• Trombetta, Claudia Maria; Ulivieri, Cristina; Cox, Rebecca Jane et al. (2018). Impact of erythrocyte species on assays for influenza serology. (external link)
• Trieu, Mai Chi; Zhou, Fan; Jalloh, Sarah Larteley Lartey et al. (2018). Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. (external link)
• Tete, Sarah; Jul-Larsen, Åsne; Rostami, Sina et al. (2018). Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine. (external link)
• Brokstad, Karl Albert; Fredriksen, Marita; Zhou, Fan et al. (2018). T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome. (external link)
• Tunheim, Gro; Laake, Ida; Robertson, Anna Hayman et al. (2018). Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness. (external link)
• Trieu, Mai Chi; Jul-Larsen, Åsne; Sævik, Marianne et al. (2018). Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: A 5-year follow-up study. (external link)
• Savic, Miloje; Dembinski, Jennifer Lynn; Laake, Ida et al. (2017). Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy. (external link)
• Jacobsen, Henning; Rajendran, Madhusudan; Choi, Angela et al. (2017). Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model. (external link)
• Dembinski, Jennifer Lynn; Mihret, Adane; Solomon, Abebe Yimer et al. (2017). High prevalence of humoral and cellular immunity to influenza viruses in preschool children living in Addis Ababa, Ethiopia. (external link)
• Mohn, Kristin Greve Isdahl; Zhou, Fan; Brokstad, Karl Albert et al. (2017). Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination. (external link)
• Islam, Shahinul; Mohn, Kristin Greve Isdahl; Krammer, Florain et al. (2017). Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. (external link)
• Andersen, Tor Kristian; Zhou, Fan; Cox, Rebecca Jane et al. (2017). A DNA vaccine that targets hemagglutinin to antigen-presenting cells protects mice against H7 influenza. (external link)
• Ebensen, Thomas; Debarry, Jennifer; Pedersen, Gabriel Kristian et al. (2017). Mucosal administration of cycle-di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in mice. (external link)
• Aase, Audun; Sommerfelt, Halvor; Petersen, Lizette Balle et al. (2016). Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction. (external link)
• Dembinski, Jennifer Lynn; Savic, Miloje; Kim, Yohan et al. (2016). Epitope specific T-cell responses against influenza A in a healthy population. (external link)
• Tete, Sarah; Krammer, Florain; Jalloh, Sarah Larteley Lartey et al. (2016). Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination. (external link)
• Voltersvik, Pål; Aqrawi, Lara Adnan; Dudman, Susanne Gjeruldsen et al. (2016). Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study. (external link)
• Trieu, Mai Chi; Zhou, Fan; Jalloh, Sarah Larteley Lartey et al. (2016). Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.. (external link)
• Eagan, Tomas Mikal; Hardie, Jon Andrew; Jul-Larsen, Åsne et al. (2016). Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. (external link)
• Héquet, Delphine; Pascual, Manuel; Lartey, Sarah Larteley et al. (2016). Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies. (external link)
• Mohn, Kristin Greve Isdahl; Brokstad, Karl Albert; Pathirana, Rishi et al. (2016). Live attenuated influenza vaccine in children induces b-cell responses in tonsils. (external link)
• Venkatesan, Sudhir; Cox, Rebecca Jane; Nguyen-Van-tam, Jonathan S. et al. (2016). Interpandemic (Seasonal) influenza. (external link)
• Manenti, Alessandro; Tete, Sarah; Mohn, Kristin Greve Isdahl et al. (2016). Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. (external link)
• Mohn, Kristin Greve Isdahl; Bredholt, Geir; Brokstad, Karl Albert et al. (2015). Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. (external link)
• Trondsen, Monica; Aqrawi, Lara Adnan; Zhou, Fan et al. (2015). Induction of local secretory IgA and multifunctional CD4+ T-helper cells following intranasal immunization with a H5N1 whole inactivated influenza virus vaccine in BALB/c mice. (external link)
• Trombetta, Claudia Maria; Perini, Daniele; Vitale, Licia et al. (2015). Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses. (external link)
• Major, Diane; Chichester, Jessica A.; Pathirana, Rishi et al. (2015). Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. (external link)
• Cox, Rebecca Jane; Major, Diane; Pedersen, Gabriel Kristian et al. (2015). Matrix M H5N1 vaccine induces cross-H5 clade humoral immune responses in a randomized clinical trial and provides protection from highly pathogenic influenza challenge in ferrets. (external link)
• Panapasa, Jack Alwin; Cox, Rebecca Jane; Mohn, Kristin Greve Isdahl et al. (2015). The expression of B & T cell activation markers in children’s tonsils following live attenuated influenza vaccine. (external link)
• Lartey, Sarah Larteley; Pathirana, Rishi; Zhou, Fan et al. (2015). Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains. (external link)
• Koch, Anne Mette; Nilsen, Roy Miodini; Dalheim, Anne et al. (2015). Need for more targeted measures - Only less severe hospital-associated infections declined after introduction of an infection control program. (external link)
• Wohlbold, Teddy John; Nachbagauer, Raffael; Xu, Haoming et al. (2015). Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. (external link)
• Eidem, Synnøve; Tete, Sarah; Jul-Larsen, Åsne et al. (2015). Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations. (external link)
• Koch, Anne Mette; Nilsen, Roy Miodini; Eriksen, Hanne-Merete et al. (2015). Mortality related to hospital-associated infections in a tertiary hospital; repeated cross-sectional studies between 2004-2011. (external link)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane; Tunheim, Gro et al. (2015). Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway. (external link)
• Sridhar, Saranya; Brokstad, Karl Albert; Cox, Rebecca Jane (2015). Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines. (external link)
• Mair-Jenkins, John; Saavedra-Campos, Maria; Baillie, J. Kenneth et al. (2015). The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. (external link)
• Krammer, Florian; Jul-Larsen, Åsne; Margine, Irina et al. (2014). An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans. (external link)
• Skrede, Steinar; Steinsland, Hans; Sommerfelt, Halvor et al. (2014). Experimental infection of healthy volunteers with enterotoxigenic Escherichia coli wild-type strain TW10598 in a hospital ward. (external link)
• Pedersen, Gabriel; Höschler, Katja; Solbak, Sara Marie Øie et al. (2014). Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. (external link)
• Mann, Alex; Noulin, Nicolas; Catchpole, Andrew et al. (2014). Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge. (external link)
• Olberg, Henning Kristian; Cox, Rebecca Jane; Nøstbakken, Jane Kristin et al. (2014). Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: An explorative study. (external link)
• Krammer, Florian; Albrecht, Randy A.; Tan, Gene S. et al. (2014). Divergent H7 immunogens offer protection from H7N9 virus challenge. (external link)
• Pedersen, Gabriel Kristian; Sjursen, Haakon; Nøstbakken, Jane Kristin et al. (2014). Matrix M™ adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4+ T cell responses in man. (external link)
• Nachbagauer, Raffael; Wohlbold, Teddy John; Hirsh, Ariana et al. (2014). Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. (external link)
• Pidelaserra Marti, Gemma; Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane et al. (2014). The Influence of Tonsillectomy on Total Serum Antibody Levels. (external link)
• Svindland, Signe; Pedersen, Gabriel Kristian; Pathirana, Rishi et al. (2013). A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. (external link)
• Pedersen, Gabriel; Madhun, Abdullah Sami; Breakwell, Lucy et al. (2012). T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. (external link)
• Svindland, Signe; Jul-Larsen, Åsne; Pathirana, Rishi et al. (2012). The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine. (external link)
• Jul-Larsen, Åsne; Madhun, Abdullah Sami; Brokstad, Karl Albert et al. (2012). The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants. (external link)
• Pathirana, Rishi; Bredholt, Geir; Akselsen, Per Espen et al. (2012). A(H1N1)pdm09 Vaccination of Health Care Workers: Improved Immune Responses in Low Responders Following Revaccination. (external link)
• Simonsen, Kristian Anton; Hunskaar, Steinar; Wensaas, Knut-Arne et al. (2012). Influenza-like illness in general practice in Norway: clinical course and attitudes towards vaccination and preventive measures during the 2009 pandemic. (external link)
• Pedersen, Gabriel; Ebensen, Thomas; Gjeraker, Ingrid Hjetland et al. (2011). Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP. (external link)
• Cox, Rebecca Jane; Pedersen, Gabriel; Madhun, Abdullah Sami et al. (2011). Evaluation of a virosomal H5N1 vaccine formulated with Matrix M (TM) adjuvant in a phase I clinical trial. (external link)
• Pedersen, Gabriel; Halstensen, Alfred; Sjursen, Haakon et al. (2011). Pandemic influenza vaccination of hypogammaglobulinemic patients induces normal or elevated influenza-specific CD4+Th1-cell responses. (external link)
• Pedersen, Gabriel; Halstensen, Alfred; Sjursen, Haakon et al. (2011). Pandemic Influenza Vaccination Elicits Influenza-Specific CD4(+) Th1-cell Responses in Hypogammaglobulinaemic Patients: Four case reports. (external link)
• Pedersen, Gabriel; Major, Diane; Roseby, Sarah et al. (2011). Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model. (external link)
• Madhun, Abdullah Sami; Haaheim, Lars Reinhardt; Nøstbakken, Jane Kristin et al. (2011). Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4(+) cells and strong mucosal and systemic antibody responses in mice. (external link)
• Madhun, Abdullah Sami; Akselsen, Per Espen; Sjursen, Haakon et al. (2010). An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. (external link)
• Cox, Rebecca Jane; Madhun, Abdullah Sami; Hauge, Solveig et al. (2009). A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. (external link)
• Madhun, Abdullah Sami; Nilsen, Mona Vibece; Haaheim, Lars Reinhardt et al. (2009). Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice. (external link)
• Cox, Rebecca Jane; Major, Diane; Hauge, Solveig et al. (2009). A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models. (external link)
• Hovden, Arnt-Ove; Brokstad, Karl Albert; Major, Diane et al. (2009). A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice. (external link)
• Hauge, Solveig; Madhun, Abdullah Sami; Cox, Rebecca Jane et al. (2007). Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies. (external link)
• Hauge, Solveig; Madhun, Abdullah Sami; Cox, Rebecca Jane et al. (2007). A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice. (external link)
• Cox, Rebecca Jane; Hovden, Arnt-Ove; Brokstad, Karl Albert et al. (2006). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (external link)
• Cox, Rebecca Jane; Haaheim, Lars Reinhardt; Eriksson, Jens Christian et al. (2006). The humoral and cellular responses induced locally and systematically after parenteral influenza vaccination in man. (external link)
• Szyszko, Ewa Alicja; Brokstad, Karl Albert; Cox, Rebecca Jane et al. (2006). Impact of influenza vaccine formulation with a detailed analysis of the cytokine response. (external link)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Madhun, Abdullah Sami et al. (2005). Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice. (external link)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Haaheim, Lars Reinhardt (2005). Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. (external link)
• Brokstad, Karl Albert; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2002). Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. (external link)
• Cox, Rebecca Jane; Mykkeltvedt, E; Robertson, J et al. (2002). Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. (external link)
• Brokstad, Rebecca Jane Cox; Mykkelstveit, Eva; Robertson, James et al. (2001). Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. (external link)
• Brokstad, Rebecca Jane Cox; Mykkelstveit, Eva; Sjursen, Haakon et al. (2001). The effect of zanamivir treatment on the early immune response to influenza vaccination. (external link)
• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox; Eriksson, Jens-Christian et al. (2001). High prevalence of influenza specific antibody secreting cells in nasal mucosa. (external link)

Academic lecture

• Cox, Rebecca Jane (2023). Local Immunity After Influenza Vaccination. (external link)
• Cox, Rebecca Jane (2023). Indo-European Consortium for Next Generation Influenza Vaccine Innovation. (external link)
• Cox, Rebecca Jane (2023). Post COVID-19 condition in children and adolescents after delta infection and omicron reinfection. (external link)
• Cox, Rebecca Jane (2022). SARS CoV-2 vaccines, what have we learnt and what is the future . (external link)
• Cox, Rebecca Jane (2022). Covid-19 vaccine evaluation. (external link)
• Cox, Rebecca Jane (2021). Influenza and SARS-CoV-2 vaccines and the young immune system: should we vaccinate children. (external link)
• Cox, Rebecca Jane (2021). Pre-existing immunity and correlates of protection for Influenza. (external link)
• Cox, Rebecca Jane (2021). Covid-19 i Bergen. (external link)
• Cox, Rebecca Jane (2020). Case study: Influenza; impact of pre-existing immunity on study end points . (external link)
• Cox, Rebecca Jane (2020). COVID-19 in the community and health care system in Bergen . (external link)
• Cox, Rebecca Jane (2020). COVID-19 in the community and health care system in Bergen, Norway. (external link)
• Cox, Rebecca Jane (2020). Influensa. (external link)
• Cox, Rebecca Jane (2019). Immune responses to influenza A/H1N1pdm09 virus after adjuvanted pandemic and seasonal influenza vaccination in healthcare workers. (external link)
• Bösl, Korbinian; Ianevski, Aleksandr; Than, Thoa T. et al. (2019). Critical Nodes of Viral Modulation Revealed Through an Integrated Network Analysis of Host-Virus Interaction Landscape. (external link)
• Cox, Rebecca Jane (2018). Should we annually vaccinate health care workers against influenza?. (external link)
• Cox, Rebecca Jane (2018). Hvorfor trenger vi fremdeles vaksiner? og Influensa en evig kamp. . (external link)
• Cox, Rebecca Jane (2018). Subject selection and screening for susceptibility to challenge. (external link)
• Cox, Rebecca Jane (2018). Should we vaccinate health care workers against influenza annually?. (external link)
• Cox, Rebecca Jane (2018). Using human influenza vaccine studies to define next generation vaccines . (external link)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane; Zhou, Fan et al. (2015). Cellular immune responses after live attenuated influenza vaccination in children, a clinical trial.. (external link)
• Trogstad, Lill; Mjaaland, Siri; Molden, Tor et al. (2014). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (external link)
• Savic, Miloje; Laake, Ida; Dembinski, Jennifer Lynn et al. (2014). The Norwegian Influenza cohort (NorFlu): immune responses in pdmH1N1 exposed versus non-exposed pregnant women. (external link)
• Savic, Miloje; Laake, Ida; Dembinski, Jennifer Lynn et al. (2014). The Norwegian Influenza cohort study (NorFlu): immune responses in H1N1 pdm exposed versus non-exposed pregnant women. (external link)
• Cox, Rebecca Jane; Eriksson, Jens-Christian Haug; Madhun, Abdullah Sami et al. (2005). The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man. (external link)
• Haaheim, Lars Reinhardt; Cox, Rebecca Jane; Brokstad, Karl Albert et al. (2004). The antibody response to parenteral influenza vaccination � A review of specificity, magnitude, rapidity and shortcomings. (external link)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
• Brokstad, Karl; Brokstad, Rebecca Jane Cox; Eriksson, Jens-Christian et al. (2002). Influenzaantigenspecific cells in human nasal mucosa. (external link)
• Brokstad, Karl; Davidsson, Åke; Eriksson, Jens-Christian et al. (2002). Influenza specific antibody secreting cells in nasal mucosa. (external link)
• Brokstad, Karl; Davidsson, Åke; Eriksson, Jens-Christian et al. (2002). Influenza-specific antibody producing cells in human nasal mucosa. (external link)
• Brokstad, Karl Albert; Davidsson, Åke; Eriksson, Jens-Christian et al. (2002). Influenza-specific antibody producing cells in human nasal mucosa. (external link)
• Eriksson, Jens-Christian; Brokstad, Karl; Brokstad, Rebecca Jane Cox et al. (2002). Influenza specific antibodysecreting cells in nasal mucosa, prior to and after vaccination. (external link)
• Davidsson, Åke; Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox et al. (2001). Influensaantigenspecifika, antikroppsproducerande lymfocyter i human nasal slemhinne. (external link)
• Brokstad, Rebecca Jane Cox; Mykkelstveit, Eva; Haaheim, Lars Reinhardt (2001). DNA vaccination with HA or NP encoding plasmids results in rapid viral clearance after viral challenge. (external link)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2001). Influenza specific antibody secreting cells (I-ASC)in human nasal mucosa. Relation to tonsil, blood and parenteral vaccination. (external link)
• Davidsson, Åke; Eriksson, Jens-Christian; Cox, Rebecca Jane et al. (2001). The level of influenzaspecific antibodysecreting cells in nasal mucosa, prior to an after vaccination. (external link)
• Brokstad, Karl Albert; Cox, Rebecca Jane; Eriksson, Jens-Christian et al. (2001). The basal level of influenza specific antibody secreting cells in healthy subjects. (external link)
• Brokstad, Rebecca Jane Cox; Mykkelstveit, Eva; Sjursen, Haakon et al. (2001). The effect of relenza treatment on the early immune response induced after influenza vaccination. (external link)
• Haaheim, Lars Reinhardt; Ibsen, Margrethe W.; Skogstrand, Monica et al. (2001). Antibodies from lymphocytes used as diagnostic markers: A novel approach. (external link)

Poster

• Yddal, Ingeborg; Lartey, Sarah; Bansal, Amit et al. (2023). Immunogenicity after influenza-vaccine in young children and pregnant women in rural Bangladesh. (external link)
• Yddal, Ingeborg; Lartey, Sarah Larteley; Bansal, Amit et al. (2023). Influenza-specific antibody responses after Influenza vaccination in young children and pregnant women in rural Bangladesh. (external link)
• Hansen, Lena; Zhou, Fan; Amdam, Håkon et al. (2019). Neuraminidase antibody responses after pandemic and seasonal influenza vaccinations: a five-year study. (external link)
• Ertesvåg, Nina; Trieu, Mai Chi; Cox, Rebecca Jane (2019). Seasonal influenza vaccination induces broad antibody responses against antigenically distinct A/H3N2 viruses. (external link)
• Hansen, Lena; Zhou, Fan; Cox, Rebecca Jane (2019). Neuraminidase Antibody Responses After Pandemic And Seasonal Vaccination: A Five-Year Study. (external link)
• Ertesvåg, Nina; Trieu, Mai Chi; Cox, Rebecca Jane (2019). Seasonal Influenza Vaccination Induces Cross-Reactive Antibodies Against A/H3N2 Viruses. (external link)
• Savic, Miloje; Dembinski, Jennifer Lynn; Laake, Ida et al. (2016). The Norwegian Influenza cohort (NorFlu): immune responses in pregnant women during the 2009 H1N1 influenza A pandemic. (external link)
• Savic, Miloje; Dembinski, Jennifer Lynn; Laake, Ida et al. (2016). Cellular correlates of protection against A(H1N1)pdm09 pandemic influenza during pregnancy. (external link)
• Trogstad, Lill; Mjaaland, Siri; Molden, Tor et al. (2014). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (external link)
• Mjaaland, Siri; Håberg, Siri Eldevik; Dembinski, Jennifer Lynn et al. (2013). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (external link)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Brokstad, Karl Albert et al. (2007). Immunisation of mice with whole inactivated avian influenza H7N1 virus vaccine. (external link)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Madhun, Abdullah Sami et al. (2005). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (external link)
• Cox, Rebecca Jane; Hovden, Arnt-Ove; Madhun, Abdullah Sami et al. (2005). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (external link)
• Madhun, Abdullah Sami; Szyszko, E; Cox, Rebecca Jane et al. (2005). The cytokine and the antibody responses after vaccination with influenza split or whole virus vaccines in mice. (external link)
• Brokstad, Karl Albert; Eriksson, Jens-Christian Haug; Cox, Rebecca Jane et al. (2005). Cytokine profile and lymphocyte pattern influenced by parenteral influenza vaccination. (external link)
• Hovden, Arnt-Ove; Brokstad, Rebecca Jane Cox; Haaland, Inger Marie et al. (2004). The humoral immune response in mice after vaccination and subsequent challenge with live influenza virus. (external link)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
• Brokstad, Rebecca Jane Cox; Hovden, Arnt Ove; Bragstad, Karoline et al. (2003). Comparison of the humoral immune response to split and whole virus vaccines in mice. (external link)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (external link)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). Local and systemic immune response to inactivated influenza vaccine. (external link)
• Hovden, Arnt Ove; Brokstad, Rebecca Jane Cox; Haaheim, Lars Reinhardt (2003). The immune response to H7N1 whole virus vaccine in mice. (external link)
• El-Madhun, Abdullah; Brokstad, Rebecca Jane Cox; Haaheim, Lars Reinhardt et al. (2003). The kinetics of the systemic and local immune response to parenteral influenza vaccination. (external link)
• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox; Eriksson, Jens-Christian et al. (2002). Influenzaantigenspecific cells in human nasal mucosa. (external link)
• Eriksson, Jens-Christian; Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox et al. (2002). Influenzaspecific antibodysecreting cells in nasal mucosa, prior to and after vaccination. (external link)
• Brokstad, Karl Albert; Davidsson, Åke; Eriksson, Jens-Christian et al. (2002). Influenza specific antibody secreting cells in nasal mucosa. (external link)

Errata

• Tran, Trung; Vaage, Eline Benno; Mehta, Adi et al. (2023). Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants (npj Vaccines, (2022), 7, 1, (174), 10.1038/s41541-022-00586-7). (external link)
• Trieu, Mai Chi; Zhou, Fan; Jalloh, Sarah Larteley Lartey et al. (2018). Publisher Correction: Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. (external link)

Letter to the editor

• Mohn, Kristin Greve-Isdahl; Bredholt, Geir; Onyango, Therese Bredholt et al. (2023). SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity. (external link)

Interview

• Grødeland, Gunnveig; Cox, Rebecca Jane; Steenbuch, Bethen et al. (2023). Nå er vinterens smittebølge her: 77.000 sårbare barn er ikke vaksinert. (external link)
• Cox, Rebecca Jane; Tøndel, Camilla; Spurkland, Anne et al. (2023). Bør alle norske barn vaksineres mot vannkopper?. (external link)
• Steenbuch, Bethen; Grødeland, Gunnveig; Cox, Rebecca Jane et al. (2023). Venter smittetopp rundt nyttår. Slik kan influensasesongen bli fremover.. (external link)
• Steenbuch, Bethen; Grødeland, Gunnveig; Cox, Rebecca Jane et al. (2023). Vaksine mot fugleinfluensa skal testes ut på mennesker i Norge. (external link)
• Holthe, Klaus; Grødeland, Gunnveig; Cox, Rebecca Jane et al. (2022). Ny vaksinestudie: – Svært viktig. (external link)
• Steenbuch, Bethen; Grødeland, Gunnveig; Cox, Rebecca Jane (2022). Til høsten kommer trolig en ny virusbølge. Men nå er vi mye bedre forberedt.. (external link)
• Cox, Rebecca Jane (2021). Slik kan koronavaksinen beskytte oss mot den neste pandemien. (external link)
• Cox, Rebecca Jane (2020). Kinesiske forskere har funnet flere risikofaktorer hos dem som døde. (external link)
• Cox, Rebecca Jane (2020). Derfor har ikke sverige strengere krav. (external link)
• Cox, Rebecca Jane (2020). Treng vi å frykte koronaviruse i noreg. (external link)
• Cox, Rebecca Jane (2020). Hvor farlig er det nye, kinesiske koronaviruset?. (external link)
• Cox, Rebecca Jane (2020). Oppfyller kriteriene for sykdom x. (external link)
• Cox, Rebecca Jane (2020). Norsk koronastudie avslører langt høyere smitterisiko i familier enn tidligere påvist. (external link)
• Cox, Rebecca Jane (2020). 19,5 millioner til koronaforskning ved uib. (external link)
• Cox, Rebecca Jane (2020). Tegnell mener lite influensa forklarer høye koronatall dette svarer norske eksperter.. (external link)
• Cox, Rebecca Jane (2020). Virusekspert om Trump-han spilte russisk-rulett. (external link)
• Cox, Rebecca Jane (2020). influensaeksperten lar seg imponere av bergen. (external link)
• Cox, Rebecca Jane (2020). Coronaviruset: Familien til Chen er isolert i Kina. (external link)
• Cox, Rebecca Jane (2020). Hva skjer om du blir smittet av coronavirus?. (external link)
• Cox, Rebecca Jane (2020). Ni spoersmaal og svar om coronaviruset. (external link)
• Cox, Rebecca Jane (2020). 10 kjappe om coronaviruset. (external link)
• Cox, Rebecca Jane (2020). Wuhan-viruset sprer seg. Nå tas det drastiske grep over hele verden. (external link)
• Cox, Rebecca Jane (2020). Hysteri samanlikna med dei gløymde krisene. (external link)
• Cox, Rebecca Jane (2020). 45 i isolasjon på Landås etter skiferie. (external link)
• Cox, Rebecca Jane (2020). Bør du unngå å ta buss og er koronaviruset farlig for gravide?. (external link)
• Cox, Rebecca Jane (2020). Professor om coronaviruset: – Ingen grunn til å bekymre seg for covid-19. (external link)
• Cox, Rebecca Jane; Mohn, Kristin Greve Isdahl (2019). Dette appa­ratet kan på 15 minutter finne ut om du har influ­ensa. (external link)
• Cox, Rebecca Jane (2018). Man flu. Dette mener ekspertene om «man flu». (external link)
• Cox, Rebecca Jane (2017). Influensasesong. (external link)
• Cox, Rebecca Jane (2017). Årlege influensavaksiner hindrar ikkje naturleg immunitet. (external link)
• Cox, Rebecca Jane (2017). 3000 prøver gav trygge svar om influensavaksinen . (external link)
• Cox, Rebecca Jane (2017). Årlege influensavaksiner hindrar ikkje naturleg immunitet. (external link)
• Cox, Rebecca Jane (2017). Årlege influensavaksinar hindrar ikkje naturleg immunitet. (external link)
• Øystese, Oddgeir; Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2014). Behandling med Tamiflu reduserte mortaliteten under Pandemien i 2009. (external link)

Editorial

• Schotsaert, Michael; Cox, Rebecca Jane; Mallett, Corey P. (2022). Editorial: Pandemic influenza vaccine approaches: Current status and future directions. (external link)
• Cox, Rebecca Jane (2013). Correlates of protection to influenza virus, where do we go from here?. (external link)
• Pedersen, Gabriel; Cox, Rebecca Jane (2012). The mucosal vaccine quandary Intranasal vs. sublingual immunization against influenza. (external link)
• Cox, Rebecca Jane; Brokstad, Karl Albert; Haaheim, Lars Reinhardt (2006). Pandemic influenza vaccine development: time is of the essence. (external link)
• Cox, Rebecca Jane; Brokstad, Karl Albert; Haaheim, Lars Reinhardt (2006). Pandernic influenza vaccine development: time is of the essence. (external link)

Popular scientific lecture

• Cox, Rebecca Jane (2022). Post Corona: Samfunn og Helse - Hva er effektene og ettervirkningene? . (external link)
• Cox, Rebecca Jane (2021). COVID-19 studie på Vestlandet. (external link)
• Cox, Rebecca Jane (2019). Hva er god helse? Når skolemedisin møter vaksinemotstand. (external link)
• Cox, Rebecca Jane (2017). Hvorfor trenger vi fortsatt vaksiner?. (external link)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2015). Ytringsfrihet. (external link)

Interview Journal

• Westin, Steinar; Cox, Rebecca Jane (2021). Klemmene på innsettelsen av Joe Biden skaper reaksjoner: Disse smittegrepene redder dem.. (external link)
• Cox, Rebecca Jane (2017). 3000 prøver gav trygge svar om influensavaksinen . (external link)

Article in business/trade/industry journal

• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox (2021). SARS-CoV-2; Mutasjoner og Varianter. . (external link)
• Brokstad, Karl Albert; Cox, Rebecca Jane (2021). SARS-CoV-2; livssyklus, mutasjoner, immunreaksjoner og vaksiner. (external link)
• Sjursen, Haakon; Talhaug, Kristine Livsdatter Aukland; Mohn, Kristin Greve Isdahl et al. (2018). Immunrespons etter levende svekket influensavksine. (external link)

Short communication

• Brokstad, Rebecca Jane Cox; Brokstad, Karl Albert; Krammer, Florian et al. (2020). Seroconversion in household members of COVID-19 outpatients.. (external link)

Feature article

• Brokstad, Rebecca Jane Cox; Brokstad, Karl Albert (2020). CoVid-19; Derfor vil ikke dødeligheten være stor hvis viruset spres i Norge Norsk helsevesen er godt forberedt på at Wuhan-viruset kan spre seg til landet og beredskapen er på plass.. (external link)
• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox (2020). Det er ikke bare antistoffer som beskytter mot covid-19.. (external link)
• Brokstad, Rebecca Jane Cox; Brokstad, Karl Albert (2020). Not just antibodies: B cells and T cells mediate immunity to COVID-19.. (external link)
• Ertesvåg, Nina; Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2018). Få en influensafri jul!. (external link)
• Cox, Rebecca Jane; Mohn, Kristin Greve Isdahl (2017). Nok tro og folelser na. (external link)
• Cox, Rebecca Jane; Mohn, Kristin Greve Isdahl (2017). Gravide – se opp for fake news!. (external link)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2015). Sølje Bergman er farligere for barn enn vaksiner. (external link)

Popular scientific article

• Ertesvåg, Nina; Brokstad, Rebecca Jane Cox; Brokstad, Karl Albert (2020). COVID-19 og jakta på ein vaksine.. (external link)
• Fjelltveit, Elisabeth Berg; Madsen, Anders; Cox, Rebecca Jane et al. (2018). Pandemivaksinen i 2009-en forberedelse til neste influensapandemi. (external link)

Programme participation

• Cox, Rebecca Jane (2020). Spørsmål og svar om koronaviruset. (external link)

Doctoral dissertation

• Islam, Shahinul; Cox, Rebecca Jane (2019). Live Attenuated Influenza Vaccine (LAIV) Immunization in Children and Adults: Lesson for Development of Universal Influenza Vaccine. (external link)
• Trieu, Mai Chi; Cox, Rebecca Jane (2018). Long-term immune response after pandemic and seasonal influenza vaccination in healthcare workers. (external link)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2016). Immune response to influenza after vaccination and infection. (external link)

Documentary

• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2013). Målet er en livsvarig supervaksine mot influensa. (external link)
• Hødnebø, Line; Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2013). Forskning på ny influensa vaksine for barn. (external link)

Reader opinion piece

• Bredholt, Geir; Pedersen, Gabriel; Pathirana, Rishi et al. (2013). A(H1N1)pdm09 Vaccination of Healthcare Workers: Improved Immune Responses in Low Responders Following Revaccination Reply. (external link)
• Wood, John; Schild, Geoffery; Cox, Rebecca Jane (2011). Lars R. Haaheim PhD (1945-2011) Obituary. (external link)
• Hauge, Solveig; Madhun, Abdullah Sami; Brokstad, Karl Albert et al. (2009). The Immunogenicity of a Cell-derived H7N1 Split Influenza Virion Vaccine in Mice. (external link)

Abstract

• Gjeraker, Ingrid Hjetland; Pedersen, Gabriel; Svindland, Signe et al. (2011). Comparison of Different Routes of Administration for Influenza Vaccines in a Murine Model. (external link)
• Pedersen, Gabriel; Cox, Rebecca Jane (2011). Influenza Specific T-Cell Responses Predict Later Neutralizing Antibody Titres in a Phase 1 Clinical Trial of a Virosomal H5N1 Vaccine Adjuvanted with Matrix-M. (external link)

Academic chapter/article/Conference paper

• Madhun, Abdullah Sami; Cox, Rebecca Jane; Haaheim, Lars Reinhardt et al. (2004). The kinetics of the systemic and local immune response to parenteral influenza vaccination. (external link)
• Cox, Rebecca Jane; Hovden, Arnt-Ove; Bragstad, Karoline et al. (2004). Comparison of the humoral immune response to split and whole virus vaccines in mice. (external link)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Haaheim, Lars Reinhardt (2004). The immune response to H7N1 whole virus vaccine in mice. (external link)
• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox; Haaheim, Lars Reinhardt (2003). Detection of antibodies to influenza virus in human mucosal tissues and fluids. (external link)

Thesis at a second degree level

• Haaland, Inger Marie; Cox, Rebecca Jane; Haaheim, Lars R. et al. (2004). The humoral immune response after influenza viral challenge of mice previously immunised with inactivated influenza vaccine. (external link)

See a complete overview of publications in Cristin.

2023-26 KlinBeForsk Interventions against Long-COVID in Norway (PanoramicNorway). 6 partners. Partner. Budget: 20 million NOK

2021-26 EU IMI2 Innovations to accelerate vaccine development vaccine development and manufacture (Inno4Vac). 41 partners. WP leader  Budget: €18.6 million. 

2021-25 EU H2020. European Corona Vaccine Trial Accelerator Platform. (Vaccelerate). 31 partners.  National coordinator and WP leader Budget: €12 million. 

2020-25 EU H2020 Indo-European Consortium for Next Generation Influenza Vaccine Innovation (INCENTIVE). 19 partners.  Partner PI children’s clinical trial. Budget: €6 million

2019-25 Research Council of Norway (RCN) An effectiveness trial (phase IV) to evaluate protection of children and pregnant women by influenza vaccine in rural Bangladesh. 3 Partners. Coordinator - RJ. Cox. Budget: 16.9 million NOK